A PHASE II, DOUBLE-BLIND, RANDOMIZED, THREE-WAY CROSSOVER, PLACEBO-CONTROLLED, PHARMACODYNAMIC STUDY OF CK-2017357 IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS ON STANDARD THERAPY
Principal Investigator(s)
Jackson,Carlayne E
Funded by
CYTOKINETICS
Research Start Date
Status
Inactive